January 5, 2015
A new $3.8 million grant will bring together clinical and bench researchers to better understand why individuals who receive anti-retroviral treatment for HIV are at greater risk for heart disease and stroke.
The good news is that the drugs being used to fight HIV are increasing life expectancy to normal levels,said University of Rochester neurologist Giovanni Schifitto, M.D., one of the co-leaders of the study.
However, one of the long-term complications is that these treatments, the infection itself, or a combination of the two are increasing risk for cardiovascular and cerebrovascular disease in this population.
Stay up to date with the Department of Neurology by subscribing to our RSS news feed